about
Cytomegalovirus infection causes an increase of arterial blood pressureAddressing the theoretical and clinical advantages of combination therapy with inhibitors of the renin-angiotensin-aldosterone system: antihypertensive effects and benefits beyond BP control.Discovery of inhibitors of insulin-regulated aminopeptidase as cognitive enhancers.Captopril avoids hypertension, the increase in plasma angiotensin II but increases angiotensin 1-7 and angiotensin II-induced perfusion pressure in isolated kidney in SHR.Olmesartan vs. ramipril in elderly hypertensive patients: review of data from two published randomized, double-blind studies.Cardiovascular risk reduction with Renin-Angiotensin aldosterone system blockade.Effects of aqueous extract of Hibiscus sabdariffa on the renin-angiotensin-aldosterone system of Nigerians with mild to moderate essential hypertension: A comparative study with lisinoprilSmall-molecule AT2 receptor agonists.First-line antihypertensive treatment in patients with pre-diabetes: rationale, design and baseline results of the ADaPT investigation.Treating patients for cardiovascular protection: combination therapy to achieve complete renin-angiotensin system blockade.Clinic and Home Blood Pressure Lowering Effect of an Angiotensin Receptor Blocker, Fimasartan, in Postmenopausal Women with Hypertension.Management of cardiovascular risk in the perimenopausal women: a consensus statement of European cardiologists and gynecologists.Improving microvascular outcomes in patients with diabetes through management of hypertension.Blocking the renin-angiotensin system: dual- versus mono-therapy.Neuropeptides: metabolism to bioactive fragments and the pharmacology of their receptors.Pharmacovigilance analysis of adverse event reports for aliskiren hemifumarate, a first-in-class direct renin inhibitor.HMG-CoA Reductase inhibitors: an updated review of patents of novel compounds and formulations (2011-2015).Diabetes and kidney disease: the role of sodium-glucose cotransporter-2 (SGLT-2) and SGLT-2 inhibitors in modifying disease outcomes.Crocin prevents acute angiotensin II-induced hypertension in anesthetized rats.Endothelin-1 receptor blockade induces upregulation of renin-angiotensin-aldosterone system expression in terms of blood pressure regulation.Antithrombotic effects of losartan in patients with hypertension complicated by atrial fibrillation: 4A (Angiotensin II Antagonist of platelet Aggregation in patients with Atrial fibrillation), a pilot study.Antihypertensive properties of tilapia (Oreochromis spp.) frame and skin enzymatic protein hydrolysates.Molecular Modeling Studies of Substituted 2,4,5-Trisubstituted Triazolinones Aryl and Nonaryl Derivatives as Angiotensin II AT1Receptor Antagonists
P2860
Q21131578-63267D6A-98DA-4DCB-9E3E-8EB2FAB8CAA1Q33783689-06B22D6A-C8F7-44CF-9846-B20BCA6E89B2Q34543485-6E26F84A-CCCC-40AB-9748-A26B0C2EB3DEQ34642815-614B8F6C-C51E-45CE-BE9A-9E396ED2C5FAQ35085669-5E3564AE-CB39-44AB-BDDF-4CDA87F9E9C9Q35203083-E0C97DAF-FA8D-4B9B-8EA1-D76910943D34Q36210118-0BC32402-ECCA-4129-8873-BDF8DD5FE755Q36400573-06A56B83-EBBC-46B3-847E-E757906210EBQ36862389-92AA4BEC-67CE-49DD-A40B-FB02B764CC67Q36873154-27B87C39-922C-4252-B4A0-10453EBFC59AQ36988736-35EFA2CD-2174-45C9-B658-75C097DE6C3BQ37020195-D2D5039A-0CC9-46A3-ABF8-7A3C99018E8DQ37427251-37132B9B-B520-4E3A-ADEB-94C5DF6E8406Q37511006-F66B1D25-B998-48C9-8DA5-34940F0E1449Q38217456-AA4A63FF-D741-4E25-8109-7E621B283E90Q38519321-5097A59F-A3DD-4498-A9E0-18B612A492C1Q38809604-DC7EAD55-4418-44D6-8D33-A8306060EB4BQ39039079-F54ADF51-3DD6-4033-8E2C-466A02CA0549Q41591738-EB2B62DD-12EC-4AA8-B408-BBCC2149E82EQ43186654-308314D6-4F4D-4B92-B421-B90D4B2CB3BBQ43416129-B0F0C4EB-02E3-4D57-9385-431123B23338Q46324397-EC83FC17-8213-4240-99B3-025E14BE4DCDQ59007997-257FE719-2053-4264-9B5F-26646C3E0D91
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
RAS inhibition in hypertension.
@ast
RAS inhibition in hypertension.
@en
type
label
RAS inhibition in hypertension.
@ast
RAS inhibition in hypertension.
@en
prefLabel
RAS inhibition in hypertension.
@ast
RAS inhibition in hypertension.
@en
P2860
P356
P1476
RAS inhibition in hypertension.
@en
P2093
M Mohsen Ibrahim
P2860
P2888
P304
P356
10.1038/SJ.JHH.1001960
P577
2006-02-01T00:00:00Z